≡ Menu

Depression treatments using SSRI and venlafaxine compared

Despite the numerous antidepressant medications available for treatment many depressed patients continue to experience symptoms of depression. Charles B. Nemeroff, affiliated with the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, and associates, reviewed 34 double-blind randomized controlled trials that compared a single serotonin-norepinephrine reuptake inhibitor (SNRI), venlafaxine, to other… Read More

Serotonin receptors differ in men and women

For reasons still unknown, the brain neurotransmitter serotonin is critical to the development and treatment of depression and chronic anxiety. An even a bigger mystery is why more women than men are affected by depression and chronic anxiety. Hristina Jovanovic, Swedish medical university Karolinska Institute, believes he may be able to show why women are… Read More

Alzheimer’s animal model treated with umbilical cord blood cell therapy

Researchers used an unique approach to target immune suppression with human umbilical cord blood cells to improve the pathology and cognitive decline associated with Alzheimer’s disease–based on a study involving mice genetically engineered for the neurodegenerative condition. Jun Tan, PhD, MD, and colleagues, performed a series of low-dose infusions of human umbilical cord blood cells… Read More

One man’s view on a politcally incorrect disease

Ian MacLeod’s blog tells the story of the spiral downward that so often happens when someone experiences chronic pain. His story begins on a Saturday morning that starts like every other Saturday morning except for the pain in his left leg. Was it the result of a little too ambitious Spring yard care? His concern… Read More

Chronic pain mapped using thermography

A lot of people with chronic pain know that the area affected feels slightly cooler to the touch. Some researchers believe that this can be caused by muscle contractions that restrict blood flow to the area. The Kathryn Walter Stein Chronic Pain Laboratory researcher, Mathew H.M. Lee, M.D., uses computerized thermography to find the ‘cool’… Read More

Drugs can be made cheaper with new gene therapy technique

For thousands of years people have considered dairy products as a folk remedy for practically every human illness–most of which are ineffective. An article in the February, 2008 journal of Federation of American Societies for Experimental Biology (FASEB) reports that researchers at the University of Pennsylvania have successfully used gene therapy to produce therapeutic proteins… Read More

How you can unwittingly help disability insurance companies deny your claim

You have probably seen surveillance footage of a fraudulent disability insurance claimant who claims to have a bad back, but is caught on camera lifting a heavy carton. What the cameras do not show is the legitimate disability claimant who is denied benefits by their insurance company. Unless you know someone personally who has been… Read More

Parkinson’s society responds to isradipine study

Parkinson’s Disease Society (PDS) responds to the Northwestern University report of isradipine as a treatment for Parkinson’s disease. Director of Research and Development for Parkinson’s Disease Society (PDS), Dr. Kieran Breen, says Parkinson’s is caused by the loss of dopamine-producing nerve cells. If this process can be reversed the symptoms of Parkinson’s would also be… Read More

Alzheimer’s risk may not be reduced by statin use

Hope was recently given to users of cholesterol lowering drugs known as statins because the suggestion was that the drug there were taking would help reduce the risk of developing Alzheimer’s disease. A new study involving 929 Catholic clergy members, with an average age of 75-years, challenges those findings. At the beginning of the study all 929 participants… Read More

Isradipine first sign of hope for Parkinson’s in 30 years

According to an article presented by PhysOrg, isradipine is the first promising major advancement in the treatment for Parkinson’s disease in 30 years. For the past 3 decades, Parkinson’s has been treated principally with L-DOPA, which is used because it converts into dopamine. Studies of Parkinson’s patients have shown that they have insufficient dopamine, which… Read More

Pain relief protein discovered in blood

Neuropathic pain is caused by nerve damage that can be associated with chronic inflammation or direct nerve injury. This type of pain differs from ordinary pain in that it is usually perceived as ongoing burning or as ‘pins and needles’ electric-shock type of sensation. It is the type of pain that often associated with shingles, cancer, repetitive… Read More

Exercising your brain reduces the risk of Alzheimer’s disease

Rush University Medical Center’s, Rush Memory and Aging Project, reports in the online edition of Neurology, that often older adults who read newspapers, play chess, or engage in other mental stimulating activity reduce the risk of developing Alzheimer’s disease. They also found visiting a library or attending a play reduces risk of mild cognitive impairment… Read More